Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?

about

Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis.

P2860

Q36035654-9DEABAE0-A2B8-4C5F-BD3B-512BE7BE8F94 Q46973105-458A3A63-557C-4A28-8619-02887FC00E30

P2860

Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?

Item

http://www.wikidata.org/entity/Q36752124

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Drug-induced immunomodulation ...... osclerosis: a new opportunity?

@en

type

Item

label

Drug-induced immunomodulation ...... osclerosis: a new opportunity?

@en

prefLabel

Drug-induced immunomodulation ...... osclerosis: a new opportunity?

@en

P1476

Drug-induced immunomodulation ...... osclerosis: a new opportunity?

@en

P2093

Lili Bai

http://www.w3.org/2001/XMLSchema#string

Marjo M P C Donners

http://www.w3.org/2001/XMLSchema#string

Mat J A P Daemen

http://www.w3.org/2001/XMLSchema#string

Sylvia Heeneman

http://www.w3.org/2001/XMLSchema#string

P2860

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Atherosclerosis

NFAT: ubiquitous regulator of cell differentiation and adaptation

Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease

Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis

Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: long-term follow-up with intravascular ultrasound

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

Low-dose aspirin for the prevention of atherothrombosis

Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice

P304

345-364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.5.2.345

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17338677

http://www.w3.org/2001/XMLSchema#string

Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?

about

P2860

P2860

Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698